Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2012; 18(18): 2280-2286
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2280
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2280
Table 1 Serum connective tissue growth factor concentrations in patients with chronic liver diseases (μg/L)
| Group | n | Median (95% CI) |
| Healthy control | 30 | 2.2 (1.6-2.8) |
| HBV carrier | 8 | 2.2 (1.5-2.9) |
| Chronic hepatitis B | 107 | 8.8 (6.0-12.3) |
| Active liver cirrhosis | 39 | 10.9 (7.0-14.6) |
- Citation: Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis. World J Gastroenterol 2012; 18(18): 2280-2286
- URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2280